Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign
- PMID: 35738812
- DOI: 10.1111/jdv.18195
Prevention and screening of melanoma in Europe: 20 years of the Euromelanoma campaign
Abstract
Euromelanoma is a Europe-wide, dermatologist-led organization that campaigns to have a public, scientific, and political impact on raising awareness of the prevention, early diagnosis, and treatment of skin cancer. The organization raises public awareness of skin cancer by providing practical support to participating countries for the roll out of yearly screening campaigns, and then builds on these campaigns by providing resources via its website to educate the general public on key skin cancer prevention measures, risk factors, and the importance of recognizing abnormal lesions through self-examination. Euromelanoma also provides a valuable platform for the scientific community, facilitating collaborations between countries and coordinating the collection of standardized data on the epidemiology, demographic and clinical characteristics, and risk factors for all forms of skin cancer. As our scientific understanding of skin cancer advances, Euromelanoma plays a key role in ensuring that the importance of skin cancer prevention, treatment, and diagnosis remains at the forefront of European and national healthcare policies. Since its creation in 1999, Euromelanoma has continued to evolve, adapt, and expand its approach to achieve these public, scientific, and political goals: the organization now has networks of dermatologists working in over 30 countries and has screened and gathered skin cancer data from around 420 000 subjects. This review highlights these achievements by providing an outline of the history of Euromelanoma and the benefits of the first decade of action and by describing the evolving approach over the past 20 years. Future Euromelanoma projects, which aim to evaluate skin cancer risk in specific populations (outdoor workers, organ transplant recipients, etc.) are also introduced, and current challenges for the Euromelanoma campaign are discussed, including the need to improve reporting of non-melanoma skin cancer cases and to raise awareness of melanoma subtypes, particularly the more difficult to diagnose nodular melanoma form.
Keywords: Euromelanoma; campaign; prevention; screening; skin cancer.
© 2022 European Academy of Dermatology and Venereology.
Similar articles
-
Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.Br J Dermatol. 2012 Aug;167 Suppl 2:99-104. doi: 10.1111/j.1365-2133.2012.11092.x. Br J Dermatol. 2012. PMID: 22881594 Review.
-
The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1455-65. doi: 10.1111/j.1468-3083.2011.04228.x. Epub 2011 Sep 23. J Eur Acad Dermatol Venereol. 2011. PMID: 21951235
-
Impact, challenges and perspectives of Euromelanoma, a pan-European campaign of skin cancer prevention.J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1317-9. doi: 10.1111/jdv.12060. Epub 2013 Jan 8. J Eur Acad Dermatol Venereol. 2013. PMID: 23294192 No abstract available.
-
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.Eur J Cancer Prev. 2012 Jan;21(1):89-95. doi: 10.1097/CEJ.0b013e3283498e14. Eur J Cancer Prev. 2012. PMID: 22001916
-
Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer?Cancer. 1995 Jan 15;75(2 Suppl):613-36. doi: 10.1002/1097-0142(19950115)75:2+<613::aid-cncr2820751403>3.0.co;2-g. Cancer. 1995. PMID: 7804987 Review.
Cited by
-
Possible Explanations for Rising Melanoma Rates Despite Increased Sunscreen Use over the Past Several Decades.Cancers (Basel). 2023 Dec 16;15(24):5868. doi: 10.3390/cancers15245868. Cancers (Basel). 2023. PMID: 38136411 Free PMC article.
-
Cancer Burden in Adolescents and Young Adults in Belgium: Trends to Incidence Stabilisation in Recent Years with Improved Survival.Cancers (Basel). 2025 May 1;17(9):1543. doi: 10.3390/cancers17091543. Cancers (Basel). 2025. PMID: 40361468 Free PMC article.
-
The Importance of Early Detection and Prevention of Atypical Skin Lesions and Other Melanoma Risk Factors in a Younger Population.Cancers (Basel). 2024 Dec 22;16(24):4264. doi: 10.3390/cancers16244264. Cancers (Basel). 2024. PMID: 39766163 Free PMC article.
-
Effect of planned visual education on university students' attitudes and beliefs regarding skin cancer: a cluster-randomized controlled trial.Sao Paulo Med J. 2025 May 30;143(4):e2024252. doi: 10.1590/1516-3180.2024.0252.R1.14022025. eCollection 2025. Sao Paulo Med J. 2025. PMID: 40465956 Free PMC article. Clinical Trial.
-
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019.Arch Dermatol Res. 2023 Dec;315(10):2893-2904. doi: 10.1007/s00403-023-02730-2. Epub 2023 Sep 29. Arch Dermatol Res. 2023. PMID: 37773351 Free PMC article. Review.
References
-
- Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120-140.
-
- Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol 2020; 1268: 123-139.
-
- World Health Organization. EPHO5: Disease prevention, including early detection of illness 2018. Available from: https://www.euro.who.int/en/health-topics/Health-systems/public-health-s.... Last accessed on May 17, 2022.
-
- Rebbeck TR. Precision prevention of cancer. Cancer Epidemiol Biomark Prev 2014; 23: 2713-2715.
-
- Loomans-Kropp HA, Umar A. Cancer prevention and screening: the next step in the era of precision medicine. NPJ Precis Oncol 2019; 3: 3.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous